首页> 外文期刊>British Journal of Pharmacology >Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis
【24h】

Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis

机译:在静脉和动脉血栓形成大鼠模型中,单克隆抗体诱导纤溶酶原激活物抑制剂1型底物形式的抗血栓形成活性

获取原文
获取原文并翻译 | 示例
       

摘要

Elevated plasminogen activator inhibitor 1 (PAI-1) is a risk factor for thrombosis, and inhibitors of the interaction between PAI-1 and tissue plasminogen activator (t-PA) have antithrombotic and pro- thrombolytic activity in animals. We describe the antithrombotic effects in the rat of a monoclonal antibody(MA33H1) which converts PAI-1 to a non-inhibitory substrate. The activity of MA33H1 against rat PAI-1 was confirmed using two-chain t-PA and a chromogenic Substrate. MA33H1 was evaluated in rat venous (thromboplastin + stasis in the abdominal vena cava) And arterial (electric current applied to a carotid artery) thrombosis models. the effects on tail- Transection bleeding time were studied.
机译:纤溶酶原激活物抑制剂1(PAI-1)升高是血栓形成的危险因素,而PAI-1与组织纤溶酶原激活物(t-PA)之间相互作用的抑制剂在动物中具有抗血栓形成和溶栓前活性。我们描述了将PAI-1转换为非抑制性底物的单克隆抗体(MA33H1)在大鼠中的抗血栓形成作用。使用双链t-PA和生色底物证实了MA33H1对大鼠PAI-1的活性。在大鼠静脉(凝血活酶+腹腔静脉淤积)和动脉(施加于颈动脉的电流)血栓模型中评估了MA33H1。研究了对尾横切出血时间的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号